Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2

Cancer Letters

Volumn 229, Issue 2, 2005, Pages 271-281

  Arce, Frederick ^a,b   Gätjens Boniche, Omar ^c   Vargas, Ernesto ^a   Valverde, Berta ^d   Díaz, Cecilia ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b Hospital Calderon Guardia   (Costa Rica)

^c INSTITUTO TECNOLÓGICO DE COSTA RICA   (Costa Rica)

^d HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

Author keywords

Apoptosis; Chemotherapy; Hepatocellular carcinoma; Retinoic acid

Indexed keywords

CASPASE 8; ISOTRETINOIN; PROCASPASE 3; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; HEPATOMA CELL; HUMAN; HUMAN CELL; PHOTOMETRY; PRIORITY JOURNAL; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; ISOTRETINOIN; LIVER NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RETINOIDS;

EID: 26444518150     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.06.047     Document Type: Article

References (47)

1. C.C. Diaconu, M. Szathmari, G. Keri, and A. Venetianer Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232 Br. J. Cancer 80 1999 1197 1203
2. Y. Murakami, K. Hayashi, S. Hirohashi, and T. Sekiya Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas Cancer Res. 51 1991 5520 5525
3. I.O. Ng, L.P. Chung, S.W. Tsang, C.L. Lam, E.C. Lai, S.T. Fan, and M. Ng p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese Oncogene 9 1994 985 990
4. T.Y. Chi, G.G. Chen, and P.B. Lai Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells Cancer J. 10 2004 190 200
5. F.H. Igney, and P.H. Krammer Death and anti-death: tumor resistance to apoptosis Nat. Rev. Cancer 2 2002 277 288
6. S. Cory, and J.M. Adams The Bcl-2 family: regulators of the cellular like-or-death switch Nat. Rev. Cancer 2 2002 647 656
7. D.M. Hockenbery, M. Zutter, W. Hickey, M. Nahm, and S.J. Korsmeyer Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death Proc. Natl Acad. Sci. USA 88 1991 6961 6965
8. F.L. Charlotte, A. Hermine, N. Martin, Y. Geleyn, M. Nollet, P. Gaulard, and E.S. Zafrani Immunohistochemical detection of Bcl-2 protein in normal and pathological human liver Am. J. Pathol. 144 1994 460 465
9. T. Takehara, X. Liu, J. Fujimoto, S.L. Friedman, and H. Takahashi Expression and role of Bcl-xL in human hepatocellular carcinomas Hepatology 34 2001 55 61
10. D. Luo, S.C.J. Cheng, and Y. Xie Effect of Bcl-2 and Bcl-xL protein levels on chemoresistance of hepatoblastoma HepG2 cell line Biochem. Cell Biol. 78 2000 119 126
11. K.R. You, M.N. Shin, R.K. Park, S.O. Lee, and D.G. Kim Activation of caspase-8 during N-(4-hydroxyphenyl) retinamide-induced apoptosis in Fas-defective hepatoma cells Hepatology 34 2001 1119 1127
12. X.M. Yin, and W.X. Ding Death receptor activation-induced hepatocyte apoptosis and liver injury Curr. Mol. Med. 3 2003 491 508
13. S. Shankar, and R.K. Srivastava Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications Drug Resist. Updat. 7 2004 139 156
14. M. Shigeno, K. Nakao, T. Ichikawa, K. Susuki, A. Kawakami, and S. Abiru Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NFkB inactivation Oncogene 22 2003 1653 1662
15. H. Takachima, T. Nakajima, M. Moriguchi, S. Sekoguchi, T. Nishikawa, and T. Watanabe In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma Liver Int. 25 2005 77 84
16. A.C. Fields, G. Cotsonis, D. Sexton, R. Santoianni, and C. Cohen Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognosis patterns and outcome Mod. Pathol. 17 2004 1778 1785
17. M. Lazzarino, M.B. Regazzi, and A. Corso Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia Leuk. Lymphoma 23 1996 539 543
18. K. Mehta Interaction of liposome-encapsulated retinoids with normal and leukemic cells Pharm. Skin 3 1989 74 80
19. L. Altucci, and H. Gronemeyer The promise of retinoids to fight against cancer Nat. Rev. Cancer 1 2001 181 193
20. Y. Muto, H. Moriwaki, and A. Saito Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma N. Engl. J. Med. 340 1999 1046 1047
21. M. Okuno, T. Sano, R. Matsushima-Nishiwaki, S. Adachi, K. Akita, and Y. Okano Apoptosis induction by acyclic retinoid: a molecular basis of clonal deletion therapy for hepatocellular carcinoma Jpn. J. Clin. Oncol. 3 2001 359 362
22. P.N. Newsome, I. Beldon, Y. Moussa, T.E. Delahooke, G. Poulopoulos, P.C. Hayes, and J.N. Plevris Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease Aliment. Pharmacol. Ther. 14 2000 1295 1301
23. C. Clemente, S. Elba, G. Buongiorno, P. Berloco, V. Guerra, and A. DiLeo Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis Cancer Lett. 178 2001 123 129
24. D. Benbrook, E. Lernhardt, and M. Pfahl A new retinoic acid receptor identified from a hepatocellular carcinoma Nature 333 1988 669 672
25. J.R. Rigas, and K.H. Dragnev Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene The Oncologist 10 2005 22 33
26. W.S. Moon, and A.S. Tarnawski Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Hum. Pathol. 34 2003 1119 1126
27. T.W.T. Leung, and P.J. Johnson Systemic therapy for hepatocellular carcinoma Semin. Oncol. 28 2001 514 520
28. F. Pettersson, A.G. Dalgleish, R.P. Bissonnette, and K.W. Colston Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax Br. J. Cancer 87 2002 555 561
29. S.Y. Sun, and R. Lotan Retinoids and their receptors in cancer development and chemoprevention Crit. Rev. Oncol. Hematol. 4 2002 41 55
30. M. Ocker, C. Herold, M. Ganslmayer, S. Zopf, E. Hahn, and D. Schuppan Potentiated anti-cancer effects on hepatoma cells by the retinoid adapalene Cancer Lett. 208 2004 51 58
31. J.S. Lee, R.A. Newman, S.M. Lippmann, M.H. Huber, T. Minor, and M.N. Raber Phase I evaluation of all-trans-retinoic acid in adults with solid tumors J. Clin. Oncol. 11 1993 959 966
32. R. Matsushima-Nishiwaki, M. Okuno, S. Adachi, T. Sano, K. Akita, and H. Moriwaki Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma Cancer Res. 61 2001 7675 7682
33. R.G. Keedwell, Y. Zhao, L.A. Hammond, S. Qin, K.Y. Tsang, and A. Reitmair A retinoid-related molecule that does not bind to clasical retinoid receptors potently induces apoptosis in human prostate cancer cells through rapid caspase activation Cancer Res. 64 2004 3302 3312
34. T. Bernas, and J.W. Dobrucki The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC Arch. Biochem. Biophys. 380 2000 108 116
35. K. Kawaguchi, M. Honda, T. Yamashita, Y. Shirota, and S. Kaneko Differential gene alterations among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization Biochem. Biophys. Res. Commun. 329 2005 370 380
36. A.A. Beg, and D. Baltimore An essential role for NF-kappaB in preventing TRN-alpha-induced cell death Science 274 1996 782 784
37. H. Nakshatri, P. Bhat-Nakshatri, D.A. Martin, R.J. Goulet Jr., and G.W. Sledge Jr. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth Mol. Cell. Biol. 17 1997 3629 3669
38. T. Hettmann, J. DiDonato, M. Karin, and J.M. Leiden An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis J. Exp. Med. 189 1999 145 158
39. C. Ward, E.R. Chilvers, M.F. Lawson, J.G. Pryde, S. Fujihara, and S.N. Farrow NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro J. Biol. Chem. 274 1999 4309 4318
40. K.R. You, J. Wen, S.T. Lee, and D.G. Kim Cytochrome c oxidase subunit III. A molecular marker for N-(4-hydroxyphenyl) retinamide-induced oxidative stress in hepatoma cells J. Biol. Chem. 277 2002 3870 3877
41. H.N. Jung IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis J. Cell. Biochem. 85 2002 334 345
42. J.S. Kim, J.M. Lee, Y.J. Chwae, Y.H. Kim, J.H. Lee, and K. Kim Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways Biochem. Pharmacol. 67 2004 1459 1468
43. C. Pratt, M. Niu, and D. White Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids J. Cell. Biochem. 90 2003 692 708
44. D.M. Shin, B.S. Glisson, F.R. Khuri, J.L. Clifford, G. Clayman, and S.E. Benner Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer J. Clin. Oncol. 20 2002 359 361
45. A.V. Jaremtchuk, E.F. Aman, W. Ponce, J.J. Zarba, A.M. Ferreo, R. Alvarez, and S.A. Vigo Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma Am. J. Clin. Oncol. 25 2002 123 125
46. N. Takahashi, K. Tamagawa, K. Shimizu, T. Fukui, and Y. Maitani Effects on M5076-hepatic metastasis of retinoic acid and N-(4-hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes Biol. Pharm. Bull. 26 2003 1060 1063
47. K. Shimizu, K. Tamagawa, N. Takahashi, K. Takayama, and Y. Maitani Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture Int. J. Pharm. 258 2003 45 53